July News: Why don’t individuals want to use digital health technologies?

Evidation and Sanofi publish the Behavioral Engagement and Activation Model Study (BEAMS)

Many individuals with Type 2 Diabetes (T2D) could benefit from digital health technologies (DHTs) but don’t use them, or stop using them too soon. We partnered with Sanofi to look at different groups of people with and without DHT use to understand who might require more tailored support to adopt DHTs and maximize their value.

Key findings include:

• People with T2D who are more activated and have high self-efficacy for managing their diabetes are more likely to use DHTs, and to keep using them.
• There are a range of reasons why individuals don’t use DHTs, including privacy, cost, the technology itself, and motivation levels.
• Providers recommending DHTs to patients with high activation and self-efficacy could be effective in increasing adoption

CTA: Read the publication

Community findings

Members report migraines impact quality of life

Evidation conducted The Migraine Experience Survey to better understand real-world experiences of individuals with migraine. Of the 21,000+ Evidation Members who engaged with the survey, 34% reported the top area of life impacted by their migraines was...

Want to keep reading? Subscribe to our monthly newsletter to get access to our latest announcements, events, and program insights!